Today: 5 February 2026
Subscribe
Browse Category

NASDAQ:PETS News 12 December 2025

PetMed Express (PETS) Stock: $4 Takeover Proposal Sparks Surge — News, Forecasts, and Key Risks on Dec. 12, 2025

PetMed Express (PETS) Stock: $4 Takeover Proposal Sparks Surge — News, Forecasts, and Key Risks on Dec. 12, 2025

Updated: Friday, December 12, 2025 (US market context). PetMed Express, Inc. (NASDAQ: PETS ) — best known as PetMeds and the parent of PetCareRx — is back on traders’ radars after a Singapore-based investor publicly disclosed an unsolicited proposal to take the online pet pharmacy private at $4.00 per share in cash . The news sent PETS sharply higher on…
12 December 2025
·····

Stock Market Today

  • Boston Scientific Shares Dive 17.5% on Disappointing 2026 Profit Guidance
    February 4, 2026, 6:32 PM EST. Boston Scientific's stock plunged 17.5% to $75.59 on Feb. 4 after its Q4 earnings beat estimates but cautious 2026 profit guidance disappointed investors. The medical-device maker delivered 16% sales growth and 14% adjusted EPS growth in Q4, outperforming Wall Street expectations. However, weak guidance for the first quarter and 2026 EPS trimmed investor optimism, with EPS projections falling slightly short. Trading volume surged 581% above its three-month average, reflecting the sharp selloff. Despite the setback, Boston Scientific's Cardiovascular segment grew sales 18%, MedSurg unit revenues rose 12%, and management forecasted $4.2 billion in free cash flow for 2026. The decline was company-specific; peers Medtronic and Stryker showed smaller losses. Investors weigh today's reaction as overdone given Boston Scientific's consistent long-term growth and double-digit sales gains across 12 quarters.
Go toTop